Dronedarone (Multaq®), a guideline recommended drug therapy option for paroxysmal and persistent atrial fibrillation (AF), has failed to deliver on the initial hopes and hype as the safer alternative to amiodarone.

The American College of Chest Physicians Antithrombotic Guidelines, 9th edition are now available.  Here's a short summary about what every clinician should know.

“See you in four weeks!” This has been a common ending to most anticoagulation clinic appointments over the years.  But perhaps it’s time for this routine to change?

The 9th edition of the ACCP Antithrombotic Therapy and Prevention of Thrombosis Guidelines are published! 

The American Academy of Family Physicians (AAFP) recently published a position paper to address their view of the pharmacist’s role in patient care.

Yet another clinical trial attempting to prove that adding a second lipid lowering agent to a statin-based regimen has failed.

For diabetes patients uncontrolled on basal insulin therapy, is adding exenatide a good choice?

A recent editorial and "open letter" published in the journal Circulation: Cardiovascular Quality and Outcomes questions the continued use of LDL targets to guide treatment decisions.